Teva Triumphs Over Merck In Temodar Patent Spat
In a blow to Merck & Co. Inc., a federal judge upheld Teva Pharmaceutical Industries Ltd.'s claims Tuesday that the patent for brain tumor treatment Temodar is unenforceable due to prosecution...To view the full article, register now.
Already a subscriber? Click here to view full article